BGMSP
Price
$5.75
Change
-$0.13 (-2.21%)
Updated
Oct 1, 11:53 AM (EDT)
Capitalization
N/A
KZIA
Price
$6.77
Change
+$0.21 (+3.20%)
Updated
Oct 6, 04:59 PM (EDT)
Capitalization
11.33M
Interact to see
Advertisement

BGMSP vs KZIA

Header iconBGMSP vs KZIA Comparison
Open Charts BGMSP vs KZIABanner chart's image
Bio Green Med Solution
Price$5.75
Change-$0.13 (-2.21%)
VolumeN/A
CapitalizationN/A
Kazia Therapeutics
Price$6.77
Change+$0.21 (+3.20%)
VolumeN/A
Capitalization11.33M
BGMSP vs KZIA Comparison Chart in %
BGMSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGMSP vs. KZIA commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGMSP is a Hold and KZIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (BGMSP: $5.88 vs. KZIA: $6.78)
Brand notoriety: BGMSP and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BGMSP: 303% vs. KZIA: 32%
Market capitalization -- BGMSP: $0 vs. KZIA: $11.33M
BGMSP [@Biotechnology] is valued at $0. KZIA’s [@Biotechnology] market capitalization is $11.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGMSP’s FA Score shows that 1 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • BGMSP’s FA Score: 1 green, 4 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, BGMSP is a better buy in the long-term than KZIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGMSP’s TA Score shows that 5 TA indicator(s) are bullish while KZIA’s TA Score has 5 bullish TA indicator(s).

  • BGMSP’s TA Score: 5 bullish, 5 bearish.
  • KZIA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, KZIA is a better buy in the short-term than BGMSP.

Price Growth

BGMSP (@Biotechnology) experienced а -0.34% price change this week, while KZIA (@Biotechnology) price change was -9.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +14.77%, and the average quarterly price growth was +84.62%.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGMSP YTD gains are higher at: -19.342 vs. KZIA (-23.390).
BGMSPKZIABGMSP / KZIA
CapitalizationN/A11.3M-
EBITDAN/A-26.77M-
Gain YTD-19.342-23.39083%
P/E RatioN/AN/A-
RevenueN/A2.31M-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BGMSP vs KZIA: Fundamental Ratings
BGMSP
KZIA
OUTLOOK RATING
1..100
501
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
97100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4362
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
509

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BGMSP's Valuation (1) in the Biotechnology industry is somewhat better than the same rating for KZIA (35). This means that BGMSP’s stock grew somewhat faster than KZIA’s over the last 12 months.

BGMSP's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as KZIA (100). This means that BGMSP’s stock grew similarly to KZIA’s over the last 12 months.

BGMSP's SMR Rating (100) in the Biotechnology industry is in the same range as KZIA (100). This means that BGMSP’s stock grew similarly to KZIA’s over the last 12 months.

BGMSP's Price Growth Rating (43) in the Biotechnology industry is in the same range as KZIA (62). This means that BGMSP’s stock grew similarly to KZIA’s over the last 12 months.

BGMSP's P/E Growth Rating (100) in the Biotechnology industry is in the same range as KZIA (100). This means that BGMSP’s stock grew similarly to KZIA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BGMSPKZIA
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 15 days ago
90%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BGMSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMR7.320.13
+1.81%
Nomura Holdings
STNG56.24-1.06
-1.85%
Scorpio Tankers
MTNB1.90-0.04
-1.96%
Matinas Biopharma Holdings Inc
AMRK25.76-0.93
-3.48%
A-Mark Precious Metals
DHX2.51-0.16
-5.99%
DHI Group

BGMSP and

Correlation & Price change

A.I.dvisor tells us that BGMSP and VALN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGMSP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGMSP
1D Price
Change %
BGMSP100%
N/A
VALN - BGMSP
24%
Poorly correlated
-3.25%
SRPT - BGMSP
23%
Poorly correlated
+2.74%
AURA - BGMSP
21%
Poorly correlated
-2.15%
KZIA - BGMSP
21%
Poorly correlated
+3.35%
TECH - BGMSP
21%
Poorly correlated
-1.64%
More